Pfizer bought G...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Global Blood Therapeutics
Pfizer bought Global Blood Therapeutics
10/5/22 at 16:56
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.
Global Blood Therapeutics
Review
Source:
investors.pfizer.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
X5 reported for 3 months of 2025 by IFRS
5/5/25
X5
Board of Directors of Krasnoyarskenergosbyt recommended that dividends be paid for 2024
5/5/25
KRSB
Rosseti Urals reported for 3 months of 2025 by RAS
5/5/25
MRKU
Board of Directors of Far-Eastern Energy Company recommended that dividends be paid for 2024
5/5/25
DVEC
JSFC Sistema has transferred control over Voskhod
5/5/25
AFKS
Buryatzoloto reported for 2024 by IFRS
5/1/25
BRZL
Globaltrack reported for 3 months of 2025 by RAS
5/1/25
GTRK
Rosinter reported for 2024 by IFRS
5/1/25
ROST
Rosinter reported for 2024 by RAS
5/1/25
ROST
Rosinter reported for 3 months of 2025 by RAS
5/1/25
ROST
«
Previous
2
3
4
5
6
7
8
9
10
11
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
investors.pfizer.com investors.pfizer.com investors.pfizer.com
English (US) 